Literature DB >> 23290704

The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study.

Esra Uzaslan1, Bassam Mahboub, Majed Beji, Chakib Nejjari, Mohamed Awad Tageldin, Javaid Ahmed Khan, Salim Nafti, Nathir M Obeidat, Abdullah Sayiner, Siraj Wali, Nauman Rashid, Abdelkader El Hasnaoui.   

Abstract

COPD is a progressive pulmonary disease which may have a profound impact on general health status and quality of life. This article presents data on the burden of COPD obtained from the BREATHE study in the Middle East, North Africa and Pakistan. This study was a large general population survey of COPD conducted in eleven countries of the region using a standardised methodology. A total of 62,086 subjects were screened, of whom 2,187 fulfilled the "epidemiological" definition of COPD. Data on symptoms, perceived disease severity, impact on work, limitations in activities and psychological distress were collected. 1,392 subjects were analysable of whom 661 (47.5%) reported experiencing an exacerbation of their respiratory condition, 49.4% reported comorbidities and 5.5% reported severe breathlessness as measured with the MRC breathlessness questionnaire. The degree of breathlessness, as well as the perceived severity, was correlated with the overall disease impact as measured with the COPD Assessment Test (p < 0.001). 374 subjects (28.4%) reported that their respiratory condition prevented them from working and this proportion rose to 47.8% in subjects who perceived their respiratory condition as severe. 47.9% of subjects reported difficulties in normal physical exertion, 37.5% in social activities and 31.7% in family activities. Psychological distress was reported by between 42.3% and 53.2% of subjects, depending on the item. In conclusion, the burden of COPD is important, and covers central aspects of daily life. For this reason, physicians should take time to discuss it with their patients, and ensure that the management strategy proposed addresses all their needs.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23290704     DOI: 10.1016/S0954-6111(12)70014-8

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  15 in total

Review 1.  Updates in Chronic Obstructive Pulmonary Disease for the Year 2014.

Authors:  Sibel Atış Naycı; Lütfi Çöplü; Alev Gürgün; Nurdan Köktürk; Mehmet Polatlı; Elif Şen; Sema Umut; Esra Uzaslan; Nurhayat Yıldırım; Peter J Barnes
Journal:  Turk Thorac J       Date:  2015-04-01

2.  The Saudi guidelines for chronic obstructive pulmonary disease: A fresh "Real-World" approach to COPD.

Authors:  Nicola A Hanania
Journal:  Ann Thorac Med       Date:  2014-04       Impact factor: 2.219

Review 3.  The epidemiology of noncommunicable respiratory disease in sub-Saharan Africa, the Middle East, and North Africa.

Authors:  Rana Ahmed; Ryan Robinson; Kevin Mortimer
Journal:  Malawi Med J       Date:  2017-06       Impact factor: 0.875

4.  Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.

Authors:  Asli Gorek Dilektasli; Ezgi Demirdogen Cetinoglu; Esra Uzaslan; Ferah Budak; Funda Coskun; Ahmet Ursavas; Ilker Ercan; Ercument Ege
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-01-05

5.  Epidemiology of chronic obstructive pulmonary disease: a population-based study in Krasnoyarsk region, Russia.

Authors:  Ivan P Artyukhov; Irina L Arshukova; Elena A Dobretsova; Tatyana A Dugina; Andrey V Shulmin; Irina V Demko
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-02

6.  A real-world evaluation of indacaterol and other bronchodilators in COPD: the INFLOW study.

Authors:  Georges Juvelekian; Waleed El-Sorougi; Chaicharn Pothirat; Faisal Yunus; Teresita De Guia; Han-Pin Kuo; Shalma Basu Patnaik; Virginia Pilipovic
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-05

7.  Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care.

Authors:  Hana Müllerová; Chao Lu; Hao Li; Maggie Tabberer
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

8.  Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013.

Authors:  Sarah H Landis; Hana Muellerova; David M Mannino; Ana M Menezes; MeiLan K Han; Thys van der Molen; Masakazu Ichinose; Zaurbek Aisanov; Yeon-Mok Oh; Kourtney J Davis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-06-06

9.  A year in the life of German patients with COPD: the DACCORD observational study.

Authors:  Roland Buhl; Carl-Peter Criée; Peter Kardos; Claus Vogelmeier; Nadine Lossi; Claudia Mailänder; Heinrich Worth
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-07-20

10.  The disease burden of chronic obstructive pulmonary disease in Greece.

Authors:  Georgia Kourlaba; Georgios Hillas; Theodoros Vassilakopoulos; Nikos Maniadakis
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.